BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes(TM) for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients

Stock Information for BioCardia Inc.

Loading

Please wait while we load your information from QuoteMedia.